ArticleFrontiers in immunology2026

Context-dependent value of HLA class I diversity in advanced non-small cell lung cancer treated with immune checkpoint blockade.

Javier Ramos-Paradas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.